BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 3974805)

  • 1. Cardiomyopathy, carnitine deficiency, and celiac disease.
    Boutrid N; Rahmoune H
    Eur J Pediatr; 2024 May; 183(5):2507-2508. PubMed ID: 38358548
    [No Abstract]   [Full Text] [Related]  

  • 2. A novel pathogenic variant in the carnitine transporter gene, SLC22A5, in association with metabolic carnitine deficiency and cardiomyopathy features.
    Jolfayi AG; Naderi N; Ghasemi S; Salmanipour A; Adimi S; Maleki M; Kalayinia S
    BMC Cardiovasc Disord; 2024 Jan; 24(1):1. PubMed ID: 38166572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left ventricular noncompaction in primary systemic carnitine deficiency: A rare association.
    Bhattacharya D; Sasikumar D; Kurup H; Krishnamoorthy KM
    Ann Pediatr Cardiol; 2021; 14(4):521-523. PubMed ID: 35527759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating modified diets and dietary supplement therapies for reducing muscle lipid accumulation and improving muscle function in neurofibromatosis type 1 (NF1).
    Vasiljevski ER; Houweling PJ; Rupasinghe T; Kaur T; Summers MA; Roessner U; Little DG; Schindeler A
    PLoS One; 2020; 15(8):e0237097. PubMed ID: 32810864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary carnitine deficiency - diagnosis after heart transplantation: better late than never!
    Grünert SC; Tucci S; Schumann A; Schwendt M; Gramer G; Hoffmann GF; Erbel M; Stiller B; Spiekerkoetter U
    Orphanet J Rare Dis; 2020 Apr; 15(1):87. PubMed ID: 32276632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Twin Brothers with Carnitine Membrane Transporter Deficiency: A Case Study.
    Dehkordi EH; Sobhani P; Asadpour N; Hashemipour M; Mostofizadeh N
    Adv Biomed Res; 2018; 7():106. PubMed ID: 30069437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exome sequencing identifies primary carnitine deficiency in a family with cardiomyopathy and sudden death.
    Lahrouchi N; Lodder EM; Mansouri M; Tadros R; Zniber L; Adadi N; Clur SB; van Spaendonck-Zwarts KY; Postma AV; Sefiani A; Ratbi I; Bezzina CR
    Eur J Hum Genet; 2017 Jun; 25(6):783-787. PubMed ID: 28295041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary carnitine deficiency and cardiomyopathy.
    Fu L; Huang M; Chen S
    Korean Circ J; 2013 Dec; 43(12):785-92. PubMed ID: 24385988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lipid storage myopathies. A clinical and pathobiochemical challenge].
    Skuban T; Klopstock T; Schoser B
    Nervenarzt; 2010 Dec; 81(12):1460-6. PubMed ID: 20401599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and genetic analysis of lipid storage myopathies.
    Ohkuma A; Noguchi S; Sugie H; Malicdan MC; Fukuda T; Shimazu K; López LC; Hirano M; Hayashi YK; Nonaka I; Nishino I
    Muscle Nerve; 2009 Mar; 39(3):333-42. PubMed ID: 19208393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A regional study of presentation and outcome of hypertrophic cardiomyopathy in infants.
    Skinner JR; Manzoor A; Hayes AM; Joffe HS; Martin RP
    Heart; 1997 Mar; 77(3):229-33. PubMed ID: 9093039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial abnormalities of muscle tissue in mice with juvenile visceral steatosis associated with systemic carnitine deficiency.
    Miyagawa J; Kuwajima M; Hanafusa T; Ozaki K; Fujimura H; Ono A; Uenaka R; Narama I; Oue T; Yamamoto K
    Virchows Arch; 1995; 426(3):271-9. PubMed ID: 7773507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary (genetic) cardiomyopathies in infancy. A survey of possible disorders and guidelines for diagnosis.
    Kohlschütter A; Hausdorf G
    Eur J Pediatr; 1986 Dec; 145(6):454-9. PubMed ID: 3545843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. l-Carnitine. A preliminary review of its pharmacokinetics, and its therapeutic use in ischaemic cardiac disease and primary and secondary carnitine deficiencies in relationship to its role in fatty acid metabolism.
    Goa KL; Brogden RN
    Drugs; 1987 Jul; 34(1):1-24. PubMed ID: 3308409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral carnitine therapy in children with cystinosis and renal Fanconi syndrome.
    Gahl WA; Bernardini I; Dalakas M; Rizzo WB; Harper GS; Hoeg JM; Hurko O; Bernar J
    J Clin Invest; 1988 Feb; 81(2):549-60. PubMed ID: 3276734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary lipid cardiomyopathy.
    Zimmermann A; Wyss P; Stocker F
    Virchows Arch A Pathol Anat Histopathol; 1990; 416(5):453-9. PubMed ID: 2107634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful carnitine treatment in two siblings having lipid storage myopathy with hypertrophic cardiomyopathy.
    Matsuishi T; Hirata K; Terasawa K; Kato H; Yoshino M; Ohtaki E; Hirose F; Nonaka I; Sugiyama N; Ohta K
    Neuropediatrics; 1985 Feb; 16(1):6-12. PubMed ID: 3974805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lipidic myopathy with severe cardiomyopathy caused by a generalized carnitine deficiency. Favourable course during carnitine hydrochloride treatment].
    Morand P; Despert F; Carrier HN; Saudubray BM; Fardeau M; Romieux B; Fauchier C; Combe P
    Arch Mal Coeur Vaiss; 1979 May; 72(5):536-44. PubMed ID: 115407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Carnitine deficiency: a treatable cardiomyopathy].
    Hirata K; Yoshioka F; Eto Y; Suzuki K; Yokochi K; Kato H; Ohta K; Terasawa M
    J Cardiogr; 1986 Mar; 16(1):217-25. PubMed ID: 3782884
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.